KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates Aug 02, 2023 5:15pm EDT
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023 Jul 31, 2023 4:05pm EDT
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic Jul 27, 2023 4:05pm EDT
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes Jul 10, 2023 7:01am EDT
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 Apr 21, 2023 7:01am EDT
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022 Mar 08, 2023 4:01pm EST
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 Feb 22, 2023 4:01pm EST
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement Jan 25, 2023 7:01am EST
